pharmaphorum8y
Ricks to succeed Lechleiter as Lilly chief
Eli Lilly's chief executive, chairman and president John Lechleiter is to step down in December, and will be replaced David Ricks, who currently leads the company’s bio-medicines division.
How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut
Eli Lilly has a long, proud history that begins ... In 2009 the company’s then-CEO John Lechleiter and his leadership team ...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
In early 2018, Dave Ricks, the chief executive of the pharmaceutical giant Eli Lilly, was on a West ... His predecessor, John ...
pharmaphorum2d
Pharma gets social – LillyPad provides platform for Lilly's corporate engagement
Daniel Ghinn explores the processes behind launching LillyPad, global pharmaceutical company Eli Lilly’s corporate ... the case for change in Lilly. And CEO John Lechleiter was also already ...